Differential contribution of metabotropic glutamate receptor 5 common allosteric binding site residues to biased allosteric agonism.


Journal

Biochemical pharmacology
ISSN: 1873-2968
Titre abrégé: Biochem Pharmacol
Pays: England
ID NLM: 0101032

Informations de publication

Date de publication:
07 2020
Historique:
received: 19 02 2020
accepted: 29 04 2020
pubmed: 8 5 2020
medline: 15 12 2020
entrez: 8 5 2020
Statut: ppublish

Résumé

Allosteric modulators of metabotropic glutamate receptor subtype 5 (mGlu

Identifiants

pubmed: 32380090
pii: S0006-2952(20)30239-2
doi: 10.1016/j.bcp.2020.114011
pii:
doi:

Substances chimiques

1-(4-(2,4-difluorophenyl)piperazin-1-yl)-2-((4-fluorobenzyl)oxy)ethanone 0
5-((3-fluorophenyl)ethynyl)-N-(3-hydroxy-3-methylbutan-2-yl)picolinamide 0
Grm5 protein, rat 0
Inositol Phosphates 0
Oxazoles 0
Piperazines 0
Pyridines 0
Receptor, Metabotropic Glutamate 5 0
VU0409551 0
Niacinamide 25X51I8RD4
Methoxyhydroxyphenylglycol 534-82-7
MAPK1 protein, human EC 2.7.11.24
MAPK3 protein, human EC 2.7.11.24
Mitogen-Activated Protein Kinase 1 EC 2.7.11.24
Mitogen-Activated Protein Kinase 3 EC 2.7.11.24
Calcium SY7Q814VUP
3,4-dihydroxyphenylglycol UEH9K539KJ

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

114011

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Kathy Sengmany (K)

Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences and Department of Pharmacology, Monash University, Parkville, VIC, Australia.

Shane D Hellyer (SD)

Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences and Department of Pharmacology, Monash University, Parkville, VIC, Australia.

Arthur Christopoulos (A)

Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences and Department of Pharmacology, Monash University, Parkville, VIC, Australia.

David J Lapinsky (DJ)

Graduate School of Pharmaceutical Sciences, Duquesne University, Pittsburgh, PA, United States.

Katie Leach (K)

Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences and Department of Pharmacology, Monash University, Parkville, VIC, Australia.

Karen J Gregory (KJ)

Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences and Department of Pharmacology, Monash University, Parkville, VIC, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH